← FDA DRUG APPROVALS

FDA ANDA · ANDA075547

THIOTEPA

Sponsor: WEST-WARD PHARMS INT

APPLICATION
ANDA075547
TYPE
ANDA
ORIGINAL APPROVAL
2001-04-02
LATEST ACTION
2015-07-08
ROUTE
INTRACAVITARY, INTRAVENOUS, INTRAVESICAL, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

THIOTEPAPrescription
THIOTEPA 15MG/VIAL · INJECTABLE · INJECTION

Approval history

2015-07-08Labeling · Supplement 6LabelAP
2001-04-02OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →